Journal profile · Pharmacology & Pharmacy
AAPS PharmSciTech
ISSN 1530-9932 · Springer International Publishing · UNITED STATES · Quarterly · Founded 2000
AAPS PharmSciTech: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 5.12; fully open access; APC about USD 4,190; median 89 days to acceptance (119 articles, last 24 months); community-reported acceptance: easy; 282 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
AAPS PharmSciTech is published by Springer International Publishing and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Drug Solubulity and Delivery Systems, Advanced Drug Delivery Systems and Advancements in Transdermal Drug Delivery, together about 49.1% of its articles. Its main subfields are Pharmaceutical Science. (generated from OpenAlex topic counts and CAS ranking data)
AAPS PharmSciTech is a peer-reviewed, online-only journal committed to serving those pharmaceutical scientists and engineers interested in the research, development, and evaluation of pharmaceutical dosage forms and delivery systems, including drugs derived from biotechnology and the manufacturing science pertaining to the commercialization of such dosage forms. Because of its electronic nature, AAPS PharmSciTech aspires to utilize evolving electronic technology to enable faster and diverse mechanisms of information delivery to its readership. Submission of uninvited expert reviews and research articles are welcomed. AAPS PharmSciTech publishes six issues a year.
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Editor-in-chief Robert O. WilliamsPublisher website
Editorial board by country: 3 in mainland China (about 4%); most named United States 35, United Kingdom 6, Italy 6, Germany 4, Mainland China 3 (71 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics21.1%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics17%
- Advancements in Transdermal Drug DeliveryPharmacology, Toxicology and Pharmaceutics10.9%
- Nanoparticle-Based Drug DeliveryMaterials Science5.1%
- Crystallization and Solubility StudiesMaterials Science4.7%
- Protein purification and stabilityBiochemistry, Genetics and Molecular Biology4%
- Analytical Methods in PharmaceuticalsChemistry3.9%
- Inhalation and Respiratory Drug DeliveryMedicine3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.12LetPub ·
- Impact factor (publisher) 2025
- 5.1Publisher website ·
- 5-year impact factor (publisher) 2025
- 4.4Publisher website ·
- CiteScore 2026-06
- 8.5LetPub ·
- SJR 2026-06
- 0.72LetPub ·
- SNIP 2026-06
- 0.95LetPub ·
- h-index
- 79LetPub ·
- h-index
- 143OpenAlex ·
- i10-index
- 3,520OpenAlex ·
- 2-year mean citedness
- 5.64OpenAlex ·
- Self-citation rate
- 5.9%LetPub ·
- Share of gold OA articles
- 20.6%LetPub ·
Volume
- Articles per year
- 269LetPub ·
- Downloads per year (publisher) 2025
- 1,500,000Publisher website ·
Articles by year OpenAlex count · 5,155 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 261 | 99 | 277 |
| 2025 | 282 | 88 | 1,544 |
| 2024 | 284 | 71 | 2,846 |
| 2023 | 238 | 68 | 3,847 |
| 2022 | 292 | 78 | 4,954 |
| 2021 | 308 | 84 | 6,396 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
89 daysMedian, submission to acceptance · P25–P75 69 days – 110 days
- Acceptance to online
- median 28 days (119 articles)
- Submission to online
- median 124 days
- Sample
- 119 articles with submission and acceptance dates (595 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2 monthsLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 30 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,190 / EUR 3,190 / GBP 2,790 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access, Peer review
- Open access Open access publishing
To find out more about publishing your work Open Access in AAPS PharmSciTech, including information on fees, funding and licences, visit our Open access publishing page.
Source ↗Publisher website ·- Peer review The AAPS Journals Make Use of Portable Peer Review
If your manuscript has been declined, and you are planning to submit your article to another of the four AAPS journals (AAPS Open, The AAPS Journal, AAPSPharmSciTech, or Pharmaceutical Research), we can help make the peer review process faster and smoother by extending the use of previous peer reviewer comments! Portable Peer Review, an opt-into service available for any author of these journals, …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer International Publishing
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 2000
- ISSN
- 1530-9932
- Society / sponsor
- American Association of Pharmaceutical Scientists
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about AAPS PharmSciTech
What CAS zone is AAPS PharmSciTech in?
In the 2025 upgraded edition of the CAS Journal Ranking, AAPS PharmSciTech is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of AAPS PharmSciTech?
The latest impact factor listed by LetPub is 5.12; CiteScore 8.5, h-index 143.
How long does peer review take at AAPS PharmSciTech?
Based on the dates recorded on 119 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 89 days (interquartile range 69–110 days); authors report an average review time of about 2 months; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of AAPS PharmSciTech based?
Of the 71 board members whose country the journal's board page names, 3 (about 4%) are in mainland China; the countries named most often are United States (35), United Kingdom (6) and Italy (6). Counted from the institutions listed on the board page; for reference only.
Which databases index AAPS PharmSciTech?
According to LetPub and DOAJ records, AAPS PharmSciTech is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase and CAS; that list has not been checked against each database.
Is AAPS PharmSciTech open access, and what is the APC?
AAPS PharmSciTech is a fully open-access journal. APC about USD 4,190.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .